These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 20382885

  • 1. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta.
    Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P.
    J Immunol; 2010 May 15; 184(10):5885-94. PubMed ID: 20382885
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH, Li XY, Ding J, Jia JF, Zhu P.
    Rheumatology (Oxford); 2008 Jan 15; 47(1):22-30. PubMed ID: 18077486
    [Abstract] [Full Text] [Related]

  • 3. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L.
    J Exp Med; 2005 Oct 17; 202(8):1075-85. PubMed ID: 16230475
    [Abstract] [Full Text] [Related]

  • 4. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?
    Razmkhah M, Jaberipour M, Erfani N, Habibagahi M, Talei AR, Ghaderi A.
    Cell Immunol; 2011 Oct 17; 266(2):116-22. PubMed ID: 20970781
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
    Zhao ZG, Li WM, Chen ZC, You Y, Zou P.
    Immunol Invest; 2008 Oct 17; 37(7):726-39. PubMed ID: 18821219
    [Abstract] [Full Text] [Related]

  • 6. Interactions between human mesenchymal stem cells and natural killer cells.
    Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M.
    Stem Cells; 2006 Jan 17; 24(1):74-85. PubMed ID: 16099998
    [Abstract] [Full Text] [Related]

  • 7. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells.
    Prigione I, Benvenuto F, Bocca P, Battistini L, Uccelli A, Pistoia V.
    Stem Cells; 2009 Mar 17; 27(3):693-702. PubMed ID: 19096038
    [Abstract] [Full Text] [Related]

  • 8. Immune protection function of multipotent mesenchymal stromal cells: role of transforming growth factor-β1.
    Zhao ZG, Cao Z, Xu W, Sun L, You Y, Li F, Li QB, Zou P.
    Cancer Invest; 2012 Nov 17; 30(9):646-56. PubMed ID: 23020627
    [Abstract] [Full Text] [Related]

  • 9. Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells.
    Petrini I, Pacini S, Petrini M, Fazzi R, Trombi L, Galimberti S.
    Eur J Clin Invest; 2009 Sep 17; 39(9):813-8. PubMed ID: 19522834
    [Abstract] [Full Text] [Related]

  • 10. Functional and phenotypic alteration of intrasplenic lymphocytes affected by mesenchymal stem cells in a murine allosplenocyte transfusion model.
    Li H, Guo ZK, Li XS, Hou CM, Tang PH, Mao N.
    Cell Transplant; 2007 Sep 17; 16(1):85-95. PubMed ID: 17436858
    [Abstract] [Full Text] [Related]

  • 11. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT.
    J Clin Invest; 1993 Dec 17; 92(6):2569-76. PubMed ID: 7504687
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
    Li Y, Qu YH, Wu YF, Wang XP, Wei J, Huang WG, Zhou DH, Fang J, Huang K, Huang SL.
    Ann Hematol; 2011 Aug 17; 90(8):873-85. PubMed ID: 21234566
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
    Ye Z, Wang Y, Xie HY, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2008 Dec 17; 7(6):608-14. PubMed ID: 19073406
    [Abstract] [Full Text] [Related]

  • 14. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR.
    Shock; 2010 Jan 17; 33(1):24-30. PubMed ID: 19996917
    [Abstract] [Full Text] [Related]

  • 15. Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.
    Faget J, Biota C, Bachelot T, Gobert M, Treilleux I, Goutagny N, Durand I, Léon-Goddard S, Blay JY, Caux C, Ménétrier-Caux C.
    Cancer Res; 2011 Oct 01; 71(19):6143-52. PubMed ID: 21852386
    [Abstract] [Full Text] [Related]

  • 16. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O, Lombardo E, Beraza A, Mancheño-Corvo P, Ramirez C, Menta R, Rico L, Camarillo E, García L, Abad JL, Trigueros C, Delgado M, Büscher D.
    Tissue Eng Part A; 2009 Oct 01; 15(10):2795-806. PubMed ID: 19231921
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
    Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC, Shi Y.
    Cell Res; 2007 Mar 01; 17(3):240-8. PubMed ID: 17325691
    [Abstract] [Full Text] [Related]

  • 18. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
    Carrión F, Nova E, Luz P, Apablaza F, Figueroa F.
    Immunol Lett; 2011 Mar 30; 135(1-2):10-6. PubMed ID: 20888363
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect.
    Choi YS, Jeong JA, Lim DS.
    Immunol Invest; 2012 Mar 30; 41(2):214-29. PubMed ID: 22017637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.